Medline Management
Management criteria checks 4/4
Medline's CEO is Jim Boyle, appointed in Jan 2023, has a tenure of 3.42 years. total yearly compensation is $3.86M, comprised of 32.4% salary and 67.6% bonuses, including company stock and options. directly owns 0.067% of the company’s shares, worth $31.73M. The average tenure of the management team and the board of directors is 3.4 years and 5.4 years respectively.
Key information
Jim Boyle
Chief executive officer
US$3.9m
Total compensation
| CEO salary percentage | 32.38% |
| CEO tenure | 3.4yrs |
| CEO ownership | 0.07% |
| Management average tenure | 3.4yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Prime Vendor Contracts And Automation Investments Will Reshape Long Term Earnings Profile
Catalysts About Medline Medline is a vertically integrated manufacturer and distributor of medical supplies and supply chain services for health care providers across acute, non-acute and international markets. What are the underlying business or industry changes driving this perspective?Medline: A Lack Of Compelling Risk-Reward Makes Me Cautious
Summary Medline delivered strong Q4 momentum and 2025 sales growth, but recent margin pressure has left profits largely flat. Medline guides for 8-9% organic sales growth and modest adjusted EBITDA gains in 2026, yet margin compression remains a material concern. Selling shareholders, including Blackstone and Carlyle, recently offloaded a significant stake post lock-up, highlighting valuation sensitivity. At $44 per share, Medline trades at 31-33x forward earnings, a demanding multiple given segment margin discrepancies and leverage. Read the full article on Seeking AlphaCEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 28 2026 | n/a | n/a | US$966m |
| Dec 31 2025 | US$4m | US$1m | US$1b |
| Sep 27 2025 | n/a | n/a | US$1b |
| Jun 28 2025 | n/a | n/a | US$1b |
| Mar 29 2025 | n/a | n/a | US$1b |
| Dec 31 2024 | US$4m | US$1m | US$1b |
Compensation vs Market: Jim's total compensation ($USD3.86M) is below average for companies of similar size in the US market ($USD14.60M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Boyle (54 yo)
Mr. James M. Boyle, also known as Jim, has been Chief Executive Officer and Director of Medline Inc. since 2023. He has been Chief Executive Officer of Medline Industries, LP since October 01, 2023 and ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$3.86m | 0.067% $ 31.7m | |
| Chief Financial Officer | 8.4yrs | US$2.56m | 0.060% $ 28.5m | |
| Chief Operating Officer | 1.4yrs | US$2.44m | 0.0028% $ 1.3m | |
| Chief Commercial Officer | 3.4yrs | US$2.55m | 0.058% $ 27.3m | |
| Chief Accounting Officer | less than a year | no data | 0.00059% $ 278.4k | |
| Chief Information Officer | 6.4yrs | no data | no data | |
| Global Head Investor Relations | no data | no data | no data | |
| Chief Legal Officer | 27.4yrs | no data | 0.0013% $ 613.4k | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Chief Marketing Officer | 1.3yrs | no data | no data | |
| Chief Human Resources Officer | 2.4yrs | US$5.34m | 0.0013% $ 613.4k | |
| Executive Vice President of Supply Chain Solutions | 3.4yrs | no data | 0.0020% $ 924.9k |
Experienced Management: MDLN's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$3.86m | 0.067% $ 31.7m | |
| Independent Director | 1.4yrs | no data | 0.19% $ 89.3m | |
| Independent Director | 5.4yrs | no data | no data | |
| Independent Director | 1.4yrs | US$375.79k | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Director | 41.4yrs | no data | 0.31% $ 146.0m | |
| Independent Director | less than a year | US$304.92k | no data | |
| Independent Director | 2.4yrs | US$150.00k | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Chairman of the Board | 41.4yrs | no data | 0.31% $ 147.5m | |
| Independent Director | 5.4yrs | no data | no data |
Experienced Board: MDLN's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/19 10:48 |
| End of Day Share Price | 2026/06/18 00:00 |
| Earnings | 2026/03/28 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medline Inc. is covered by 29 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Glen Santangelo | Barclays |
| Lee Hambright | Bernstein |